Announce Date | 07/23/2025 |
EPS Normalized Actual | $0.02 In Line |
EPS GAAP Actual | $0.02 In Line |
Revenue Actual | $0.108813B |
Revenue Surprise | Beat by $108.813M |
Announce Date | 10/01/2025 (Pre-Market) |
EPS Normalized Estimate | $0.304 |
EPS GAAP Estimate | $0.304 |
Revenue Estimate | $0.171688B |
Fiscal Period Ending | EPS Estimate | Forward PE | Low | High | # of Analysts |
---|---|---|---|---|---|
Dec 2028 | 1.2 | 14.08 | 1.16646 | 1.24373 | 1 |
Dec 2027 | 1.33 | 12.7 | 1.16576 | 1.43759 | 1 |
Period | EPS | Beat / Miss | Revenue | YoY | Beat / Miss |
---|---|---|---|---|---|
FQ2 2025 (Jun 2025) | -0.31 | -0.31 | 0.108813B | 15.46% | 108.81M |
FQ1 2025 (Mar 2025) | -0.58 | -0.58 | 0.095933B | 0.69% | 95.93M |
FQ4 2024 (Dec 2024) | -0.68 | -0.68 | 0.092167B | -36.01% | 92.17M |
FQ3 2024 (Sep 2024) | -0.9 | -0.9 | 0.081102B | -67.11% | 81.1M |
FQ2 2024 (Jun 2024) | -0.47 | -0.47 | 0.09199B | -99.95% | 91.99M |
FQ1 2024 (Mar 2024) | -0.88 | -0.88 | 0.095269B | -160.78% | 95.27M |
FQ4 2023 (Dec 2023) | -0.47 | -0.47 | 0.125353B | -131.81% | 125.35M |
FQ3 2023 (Sep 2023) | -0.49 | -0.49 | 0.13553B | -110.82% | 135.53M |
FQ4 Announce Date
10/01/2025 (Pre-Market)
Consensus EPS Estimates
0.304
Consensus Revenue Estimates
0.171688B
Fiscal Period Ending | EPS Estimate | YoY Growth(%) | Low | High | # of Analysts |
---|---|---|---|---|---|
FQ4 2027 (Dec 2027) | 0.32 | -- | 0.31145 | 0.32643 | 5 |
FQ3 2027 (Sep 2027) | 0.31 | -- | 0.30172 | 0.31623 | 2 |
FQ2 2027 (Jun 2027) | 0.32 | -- | 0.31145 | 0.32643 | 2 |
FQ1 2027 (Mar 2027) | 0.3 | -- | 0.29199 | 0.30602 | 2 |
FQ4 2026 (Oct 2026) | 0.3592 | -- | 0.33649 | 0.39119 | 3 |
FQ3 2026 (Jul 2026) | 0.2921 | -- | 0.27363 | 0.31812 | 4 |
FQ2 2026 (Jun 2026) | 0.41368 | 174.94 | 0.38723 | 0.43002 | 4 |
FQ1 2026 (Mar 2026) | 0.36983 | 256.83 | 0.34619 | 0.38443 | 5 |
Fiscal Period Ending | Revenue Estimate | YoY Growth(%) | Low | High | # of Analysts |
---|---|---|---|---|---|
FQ4 2027 (Dec 2027) | 0.16B | -- | 0.15B | 0.16B | 6 |
FQ3 2027 (Sep 2027) | 0.15B | -- | 0.15B | 0.16B | 3 |
FQ2 2027 (Jun 2027) | 0.15B | -- | 0.15B | 0.15B | 3 |
FQ1 2027 (Mar 2027) | 0.15B | -- | 0.14B | 0.15B | 3 |
FQ4 2026 (Oct 2026) | 0.2B | -- | 0.19B | 0.21B | 4 |
FQ3 2026 (Jul 2026) | 0.18B | -- | 0.17B | 0.19B | 5 |
FQ2 2026 (Jun 2026) | 0.19B | 43.74 | 0.18B | 0.2B | 5 |
FQ1 2026 (Mar 2026) | 0.18B | 45.85 | 0.17B | 0.18B | 6 |
EPS # of Up Revisions
4
EPS # of Down Revisions
4
Revenue # of Up Revisions
6
Revenue # of Down Revisions
3
Fiscal Period Ending | EPS Estimate | YoY Growth | Low | High | # of Analysts |
---|---|---|---|---|---|
FQ4 2021 (Dec 2021) | 0.41 | -12.52% | 0.39 | 0.48 | 20 |
FQ1 2022 (Mar 2022) | 0.59 | 6.89% | 0.55 | 0.62 | 15 |
FQ2 2022 (Jun 2022) | 0.70 | 2.62% | 0.61 | 0.74 | 15 |
FQ3 2022 (Sep 2022) | 0.68 | 4.62% | 0.65 | 0.70 | 15 |
Fiscal Period Ending | EPS Estimate | YoY Growth | Low | High | # of Analysts |
---|---|---|---|---|---|
FQ4 2021 (Dec 2021) | 0.41 | -12.52% | 0.39 | 0.48 | 20 |
FQ1 2022 (Mar 2022) | 0.59 | 6.89% | 0.55 | 0.62 | 15 |
FQ2 2022 (Jun 2022) | 0.70 | 2.62% | 0.61 | 0.74 | 15 |
FQ3 2022 (Sep 2022) | 0.68 | 4.62% | 0.65 | 0.70 | 15 |
EPS # of Beats
0
EPS # of Misses
8
EPS # of in-lines
0
Revenue # of Beats
8
Revenue # of Misses
0
Revenue # of in-lines
0
Earnings Date | EPS Estimate | EPS Actual | Surprise | Surprise % |
---|---|---|---|---|
FQ2 2025 (Jun 2025) | -0.31 | -0.31 | 100% | |
FQ1 2025 (Mar 2025) | -0.58 | -0.58 | 100% | |
FQ4 2024 (Dec 2024) | -0.68 | -0.68 | 100% | |
FQ3 2024 (Sep 2024) | -0.9 | -0.9 | 100% | |
FQ2 2024 (Jun 2024) | -0.47 | -0.47 | 100% | |
FQ1 2024 (Mar 2024) | -0.88 | -0.88 | 100% | |
FQ4 2023 (Dec 2023) | -0.47 | -0.47 | 100% | |
FQ3 2023 (Sep 2023) | -0.49 | -0.49 | 100% |
Earnings Date | Revenue Estimate | Revenue Actual | Surprise | Surprise % |
---|---|---|---|---|
FQ2 2025 (Jun 2025) | $0B | $0.11B | $108.81M | 100% |
FQ1 2025 (Mar 2025) | $0B | $0.1B | $95.93M | 100% |
FQ4 2024 (Dec 2024) | $0B | $0.09B | $92.17M | 100% |
FQ3 2024 (Sep 2024) | $0B | $0.08B | $81.1M | 100% |
FQ2 2024 (Jun 2024) | $0B | $0.09B | $91.99M | 100% |
FQ1 2024 (Mar 2024) | $0B | $0.1B | $95.27M | 100% |
FQ4 2023 (Dec 2023) | $0B | $0.13B | $125.35M | 100% |
FQ3 2023 (Sep 2023) | $0B | $0.14B | $135.53M | 100% |